Medtech InsightWall Street analysts support Abbott ’s planned $890m acquisition of Cardiovascular Systems (CSI) as a relatively inexpensive way for Abbott to expand its presence in the peripheral intervention mar
Medtech Insight[ Editor's Note: Due to a technical issue, some of this article did not appear online when it was originally published on 1 November, so we are republishing it in its entirety. ] Johnson & Johnson
Medtech InsightUS FDA issued a draft guidance document July 27 for peripheral vascular atherectomy devices, asking sponsors submit clinical evidence to help prove the new devices are substantially equivalent to th
Medtech InsightA Los Angeles county jury has awarded a total of $25m to a man who accused his former employer, coronary and vascular device manufacturer Cardiovascular Systems Inc. , of retaliation and unlawful t